Fairness and Transparency in an Expanded Access Program: Allocation of the Only Treatment for SMA1. | Am J Bioeth;17(10): 71-73, 2017 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Fairness and Transparency in an Expanded Access Program: Allocation of the Only Treatment for SMA1.

Burgart, Alyssa M; Collier, Julie; Cho, Mildred K.

Affiliation

Burgart AM; a Stanford University.
Collier J; a Stanford University.
Cho MK; a Stanford University.

Am J Bioeth ; 17(10): 71-73, 2017 10.

Article in En | MEDLINE | ID: mdl-29020542

Subject(s)

Compassionate Use Trials/ethics; Health Care Rationing/ethics; Patient Selection/ethics; Spinal Muscular Atrophies of Childhood/drug therapy; Ethics, Medical; Humans; Infant; United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Rationing / Spinal Muscular Atrophies of Childhood / Patient Selection / Compassionate Use Trials Limits: Humans / Infant Country/Region as subject: America do norte Language: En Journal: Am J Bioeth Journal subject: ETICA Year: 2017 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Rationing / Spinal Muscular Atrophies of Childhood / Patient Selection / Compassionate Use Trials Limits: Humans / Infant Country/Region as subject: America do norte Language: En Journal: Am J Bioeth Journal subject: ETICA Year: 2017 Type: Article